SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-015015
Filing Date
2024-02-16
Accepted
2024-02-16 19:27:49
Documents
2
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1966
2 POWER OF ATTORNEY ea193957ex24_cerotherap.htm EX-24 7262
  Complete submission text file 0001213900-24-015015.txt   10837
Mailing Address C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Byrnes Michael (Reporting) CIK: 0001619893 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40877 | Film No.: 24650148

Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)